标题
Strategies for Cancer Vaccine Development
作者
关键词
-
出版物
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Volume 2010, Issue -, Pages 1-13
出版商
Hindawi Limited
发表日期
2010-07-13
DOI
10.1155/2010/596432
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
- (2014) A. M. Hernandez et al. JOURNAL OF IMMUNOLOGY
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma
- (2009) W. Z. Ai et al. BLOOD
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy
- (2009) Vittore Cereda et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
- (2009) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cell-based therapeutic cancer vaccines: what we have and what we need
- (2009) Pawel Kalinski et al. Future Oncology
- Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
- (2009) Leisha A. Emens et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
- (2009) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- The cancer vaccine roller coaster
- (2009) Bruce Goldman et al. NATURE BIOTECHNOLOGY
- Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery
- (2009) Simon R. Best et al. VACCINE
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
- Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck
- (2008) P Michaluart et al. CANCER GENE THERAPY
- Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
- (2008) C. T. Garnett et al. CLINICAL CANCER RESEARCH
- Allogeneic Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
- (2008) D. Laheru et al. CLINICAL CANCER RESEARCH
- Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
- (2008) J. L. Gulley et al. CLINICAL CANCER RESEARCH
- Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant
- (2008) R. J. Lechleider et al. CLINICAL CANCER RESEARCH
- Immune surveillance: a balance between protumor and antitumor immunity
- (2008) Suzanne Ostrand-Rosenberg CURRENT OPINION IN GENETICS & DEVELOPMENT
- Current prospects for mRNA gene delivery
- (2008) Ayako Yamamoto et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Heat-shock proteins as powerful weapons in vaccine development
- (2008) Azam Bolhassani et al. Expert Review of Vaccines
- Clinical development of MVA-based therapeutic cancer vaccines
- (2008) Bruce Acres et al. Expert Review of Vaccines
- Promises and challenges for the development ofListeria monocytogenes-based immunotherapies
- (2008) Dirk G Brockstedt et al. Expert Review of Vaccines
- Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
- (2008) Alessandro Testori et al. JOURNAL OF CLINICAL ONCOLOGY
- An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
- (2008) Christopher Wood et al. LANCET
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
- (2008) M Campoli et al. ONCOGENE
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
- (2008) F. S. Hodi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specificity in cancer immunotherapy
- (2008) Andrea Schietinger et al. SEMINARS IN IMMUNOLOGY
- Plasmid DNA- and messenger RNA-based anti-cancer vaccination
- (2007) Benjamin Weide et al. IMMUNOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now